YAP1 is overexpressed in many cancers, such as colorectal, lung, liver, ovarian, and prostate cancers, and promotes tumor formation and development (Zhou et al., 2018; Nguyen and Yi, 2019; White et al., 2019; Yang et al., 2020). Here, YAP1 is linked to prostate cancer.